Post Essential Thrombocythaemia Myelofibrosis (PET-MF)
2 clinical trials · Condition
◉ Watch Post Essential Thrombocythaemia Myelofibrosis (PET-MF)
| Record | Firm | Date |
|---|---|---|
| Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF) (NCT01558739) | Novartis Pharmaceuticals | 2012-05-01 |
Track Post Essential Thrombocythaemia Myelofibrosis (PET-MF) automatically
Every clearance here is in the API, with alerts when new ones post.